Side effects of mifepristone-misoprostol abortion versus surgical abortion - Data from a trial in China, Cuba, and India

被引:33
作者
Elul, B
Ellertson, C
Winikoff, B
Coyaji, K
机构
[1] Populat Council, New York, NY 10017 USA
[2] Populat Council, Mexico City, DF, Mexico
[3] King Edward Mem Hosp, Dept Obstet & Gynecol, Pune, Maharashtra, India
关键词
side effects; early abortion; mifepristone-misoprostol; surgical abortion; medical abortion;
D O I
10.1016/S0010-7824(99)00003-7
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Although serious adverse events of early abortion have been studied, little attention has been paid to the more common side effects experienced by early medical or surgical abortion clients. Using data from a multicenter comparative trial of women less than or equal to 56 days' gestation in China, Cuba, and India (n = 1373), side effects experienced by mifepristone-misoprostol medical abortion and surgical abortion clients were analyzed at the different stages of their abortions. Data on side effects came from women's reports at each clinic visit, providers' observations during the clinic visits, and symptom diaries maintained during the study period. Medical abortion clients at all sites experienced more side effects than their surgical counterparts. The disparity between the two groups was particularly pronounced for bleeding and pain. Despite more reports of side effects among medical abortion clients, however, assessments of well-being and reports of satisfaction at the exit interview were similar in both treatment groups. (C) 1999 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:107 / 114
页数:8
相关论文
共 15 条
[1]   The use of misoprostol for termination of early pregnancy [J].
Carbonell, JLL ;
Varela, L ;
Velazco, A ;
Fernandez, C .
CONTRACEPTION, 1997, 55 (03) :165-168
[2]   BLOOD-LOSS IN TERMINATION OF EARLY-PREGNANCY BY VACUUM ASPIRATION AND BY COMBINATION OF MIFEPRISTONE AND GEMEPROST [J].
CHAN, YF ;
HO, PC ;
MA, HK .
CONTRACEPTION, 1993, 47 (01) :85-95
[3]   METHOTREXATE AND MISOPROSTOL FOR EARLY ABORTION [J].
CREININ, MD ;
DARNEY, PD .
CONTRACEPTION, 1993, 48 (04) :339-348
[4]  
ELLERTSON C, IN PRESS J AM MED WO
[5]   Blood loss with mifepristone-misoprostol abortion: measures from a trial in China, Cuba and India [J].
Harper, C ;
Winikoff, B ;
Ellertson, C ;
Coyaji, K .
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 1998, 63 (01) :39-49
[6]   Safety, efficacy and acceptability of mifepristone-misoprostol medical abortion in Vietnam [J].
Ngoc, NTN ;
Winikoff, B ;
Clark, S ;
Ellertson, C ;
Am, KN ;
Hieu, DT ;
Elul, B .
INTERNATIONAL FAMILY PLANNING PERSPECTIVES, 1999, 25 (01) :10-+
[7]   EARLY TERMINATION OF PREGNANCY WITH MIFEPRISTONE (RU-486) AND THE ORALLY ACTIVE PROSTAGLANDIN MISOPROSTOL [J].
PEYRON, R ;
AUBENY, E ;
TARGOSZ, V ;
SILVESTRE, L ;
RENAULT, M ;
ELKIK, F ;
LECLERC, P ;
ULMANN, A ;
BAULIEU, EE .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (21) :1509-1513
[8]   BLOOD-LOSS IN TERMINATION OF EARLY-PREGNANCY WITH MIFEPRISTONE AND GEMEPROST [J].
PRASAD, RNV ;
CHOOLANI, M ;
RATNAM, SS .
AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 1995, 35 (03) :329-331
[9]   BLOOD-LOSS FOLLOWING INDUCTION OF EARLY ABORTION USING MIFEPRISTONE (RU-486) AND A PROSTAGLANDIN ANALOG (GEMEPROST) [J].
RODGER, MW ;
BAIRD, DT .
CONTRACEPTION, 1989, 40 (04) :439-447
[10]  
Schaff EA, 1997, J FAM PRACTICE, V44, P353